These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36199105)

  • 21. The Clinical Tumor Lysis Syndrome in a Patient with Mixed Phenotype Acute Leukemia Undergoing Induction with Venetoclax and Azacitidine: A Case Report.
    Drozd-Sokolowska J; Mądry K; Siewiorek K; Feliksbrot-Bratosiewicz M; Stokłosa T; Gierej B; Stefaniak A; Paszkowska-Kowalewska M; Sokołowski J; Sankowski B; Basak GW
    Chemotherapy; 2022; 67(3):173-177. PubMed ID: 35325891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical Characteristics of Patients with Ph
    Jia YN; Li Y; Gong XY; Liu KQ; Ye L; Wang HJ; Li QH; Li CW; Wang Y; Wang JX; Mi YC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):354-359. PubMed ID: 30998137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixed-phenotypic acute leukemia series from tertiary care center.
    Pawar RN; Banerjee S; Bramha S; Krishnan S; Bhattacharya A; Saha V; Chakrapani A; Bhave S; Chandy M; Nair R; Parihar M; Arora N; Mishra DK
    Indian J Pathol Microbiol; 2017; 60(1):43-49. PubMed ID: 28195090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].
    Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on the clinical characteristics of 32 patients with mixed phenotype acute leukemia].
    Zhang YM; Wu DP; Sun AN; Qiu HY; Sun YM; He GS; Jin ZM; Tang XW; Miao M; Fu ZZ; Han Y; Chen SN; Zhu MQ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):12-6. PubMed ID: 21429394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiparametric Flow Cytometry in Mixed Phenotype Acute Leukemia.
    Koulmane Laxminarayana SL; Madireddy N; Manohar C; Udupa K
    Indian J Hematol Blood Transfus; 2019 Jul; 35(3):451-458. PubMed ID: 31388256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laboratory characterization of the pediatric B/T subtype of mixed-phenotype acute leukemia: Report of a case series.
    Demina I; Mikhailova E; Zerkalenkova E; Semchenkova A; Roumiantseva J; Borkovskaya A; Matveev E; Abramov D; Konovalov D; Miakova N; Ponomareva N; Belkina J; Kondratchik K; Olshanskaya Y; Novichkova G; Karachunskiy A; Popov A
    Am J Clin Pathol; 2024 Aug; 162(2):180-190. PubMed ID: 38513276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia.
    Wang Q; Cai WZ; Wang QR; Zhu MQ; Yan LZ; Yu Y; Bao XB; Shen HJ; Yao H; Xie JD; Zhang TT; Zhang L; Xu XY; Shan Z; Liu H; Cen JN; Liu DD; Pan JL; Lu DR; Chen J; Xu Y; Zhang R; Wang Y; Xue SL; Miao M; Han Y; Tang XW; Qiu HY; Sun AN; Huang JY; Dai HP; Wu DP; Chen SN
    Am J Hematol; 2023 Jan; 98(1):66-78. PubMed ID: 36219502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report.
    Naghashpour M; Lancet J; Moscinski L; Zhang L
    Am J Hematol; 2010 Jun; 85(6):451-4. PubMed ID: 20513125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recognizing Minor Leukemic Populations with Monocytic Features in Mixed-Phenotype Acute Leukemia by Flow Cell Sorting Followed by Cytogenetic and Molecular Studies: Report of Five Exemplary Cases.
    Semchenkova A; Zerkalenkova E; Demina I; Kashpor S; Volchkov E; Zakharova E; Larin S; Olshanskaya Y; Novichkova G; Maschan A; Maschan M; Popov A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunophenotypic and Clinical Characteristics of
    Liu SY; Zhu L; Wang CY; He C; Yi SJ; Meng L; Xiao M; Mao X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1639-1646. PubMed ID: 38071040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiparameter flow cytometry applications in the diagnosis of mixed phenotype acute leukemia.
    Porwit A; Béné MC
    Cytometry B Clin Cytom; 2019 May; 96(3):183-194. PubMed ID: 31033213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia.
    Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D
    Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinico-hematological and immunophenotypic profile of acute leukemia of ambiguous lineage: A four year experience from a single tertiary care centre of West India.
    Rai V; Brahmbhatt B; Saha A; Thayakaran IP
    Indian J Pathol Microbiol; 2024; 67(1):121-127. PubMed ID: 38358200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Favorable response of a patient with primary B/myeloid mixed phenotype acute Leukemia to CD19-CAR-T: Case report and literature review.
    Wang L; Pang Y; Fang C; Zhao W; Xu Y; Guo X; Qiao J; Mei J; Wang H; Yu C; Li Y; Tang Z; Yu L
    Medicine (Baltimore); 2023 Dec; 102(50):e36397. PubMed ID: 38115347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-lymphoid/myeloid mixed phenotype acute leukemia and early T-cell precursor lymphoblastic leukemia similarities with
    Noronha EP; Marques LVC; Andrade FG; Sardou-Cezar I; Dos Santos-Bueno FV; Zampier CDP; Terra-Granado E; Pombo-de-Oliveira MS
    Cancer Manag Res; 2019; 11():3933-3943. PubMed ID: 31118806
    [No Abstract]   [Full Text] [Related]  

  • 37. Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification.
    Matutes E; Pickl WF; Van't Veer M; Morilla R; Swansbury J; Strobl H; Attarbaschi A; Hopfinger G; Ashley S; Bene MC; Porwit A; Orfao A; Lemez P; Schabath R; Ludwig WD
    Blood; 2011 Mar; 117(11):3163-71. PubMed ID: 21228332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venetoclax in Combination with Hypomethylating Agents for the Treatment of Treatment-Naive B/Myeloid Mixed-Phenotype Acute Leukemia and Relapsed/Refractory Acute Myeloid Leukemia: A Report of 3 Cases.
    Wang N; He J; Liu F
    Chemotherapy; 2022; 67(3):178-182. PubMed ID: 35306492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mixed-phenotype acute leukemia characteristics: first report from Iran.
    Poopak B; Khosravi A; Bahoush-Mehdiabadi G; Madani T; Khodadi E; Farahani Z; Vahedi AA; Khosravipour G; Poopak P; Poopak AH
    Clin Exp Med; 2018 Nov; 18(4):513-521. PubMed ID: 30019150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients.
    Rasekh EO; Osman R; Ibraheem D; Madney Y; Radwan E; Gameel A; Abdelhafiz A; Kamel A; Elfishawi S
    Ann Hematol; 2021 Mar; 100(3):699-707. PubMed ID: 33230570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.